標(biāo)題: Titlebook: Cell-Based Therapy for Degenerative Retinal Disease; Marco A. Zarbin,Mandeep S. Singh,Ricardo P. Casaro Book 2019 Springer Nature Switzerl [打印本頁] 作者: Traction 時(shí)間: 2025-3-21 16:59
書目名稱Cell-Based Therapy for Degenerative Retinal Disease影響因子(影響力)
書目名稱Cell-Based Therapy for Degenerative Retinal Disease影響因子(影響力)學(xué)科排名
書目名稱Cell-Based Therapy for Degenerative Retinal Disease網(wǎng)絡(luò)公開度
書目名稱Cell-Based Therapy for Degenerative Retinal Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cell-Based Therapy for Degenerative Retinal Disease被引頻次
書目名稱Cell-Based Therapy for Degenerative Retinal Disease被引頻次學(xué)科排名
書目名稱Cell-Based Therapy for Degenerative Retinal Disease年度引用
書目名稱Cell-Based Therapy for Degenerative Retinal Disease年度引用學(xué)科排名
書目名稱Cell-Based Therapy for Degenerative Retinal Disease讀者反饋
書目名稱Cell-Based Therapy for Degenerative Retinal Disease讀者反饋學(xué)科排名
作者: patriarch 時(shí)間: 2025-3-22 00:10
Organization Design and Engineeringtinal cell-based therapy for the treatment of several retinal diseases. There is enormous promise for regenerative medicine to treat retinal diseases and preserve vision, but important issues still need to be resolved before translational clinical use.作者: 亂砍 時(shí)間: 2025-3-22 00:51
Organization Design and Engineeringa cell fusion-mediated reprogramming of retinal cells..Here, we will briefly introduce the most common degenerative retinal diseases, discuss the potential sources of stem cells for retinal disease treatment, and report the different mechanisms through which cell therapy can exert its beneficial effects.作者: 現(xiàn)任者 時(shí)間: 2025-3-22 06:50 作者: 眨眼 時(shí)間: 2025-3-22 11:05 作者: FECT 時(shí)間: 2025-3-22 15:09 作者: FECT 時(shí)間: 2025-3-22 19:22 作者: mortuary 時(shí)間: 2025-3-23 00:16
Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System,ninvasive imaging technology permits visualization and functional assessment of the transplanted cells in situ. These imaging and monitoring capabilities permit development of an iterative pathway to successful transplant paradigms in human patients as well as precise modulation of immunotherapy should it be needed.作者: 遺留之物 時(shí)間: 2025-3-23 04:53 作者: Disk199 時(shí)間: 2025-3-23 08:26
2196-8985 usses the challenges that must be managed in order to transi.This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the lab作者: 細(xì)微的差異 時(shí)間: 2025-3-23 11:34
Strategy # 5: Long/Short-Put Strategy,ninvasive imaging technology permits visualization and functional assessment of the transplanted cells in situ. These imaging and monitoring capabilities permit development of an iterative pathway to successful transplant paradigms in human patients as well as precise modulation of immunotherapy should it be needed.作者: BUDGE 時(shí)間: 2025-3-23 16:54
https://doi.org/10.1057/9781137351579neration. Reversal of glucose starvation of cones represents a potential therapeutic intervention that would be of great benefit to patients regardless of the genetic mutation in rods responsible for RP.作者: CHOKE 時(shí)間: 2025-3-23 20:19 作者: Limerick 時(shí)間: 2025-3-24 00:08
Restoration of Cone Photoreceptor Function in Retinitis Pigmentosa (RP): Retinal Cell-Based Therapyneration. Reversal of glucose starvation of cones represents a potential therapeutic intervention that would be of great benefit to patients regardless of the genetic mutation in rods responsible for RP.作者: ALERT 時(shí)間: 2025-3-24 05:00
Future Directions,ate assessment of the efficacy of retinal stem cell therapy in phase 3 clinical trials. Greater regulatory oversight and public education are needed to eliminate the dangers associated with direct-to-consumer cell therapy, so that the progress of properly designed and supervised clinical trials is not impeded.作者: 項(xiàng)目 時(shí)間: 2025-3-24 07:41
2196-8985 of “de-risking” that can be done with preclinical experimentation. This book is essential reading for?scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology..978-3-030-05222-5Series ISSN 2196-8985 Series E-ISSN 2196-8993 作者: 暫時(shí)過來 時(shí)間: 2025-3-24 10:54 作者: floodgate 時(shí)間: 2025-3-24 15:25 作者: 無能性 時(shí)間: 2025-3-24 22:57
The Role of Emotions in Coachingbeen approved as marketed products. Conventional small-scale tissue culture flask based manufacturing methods are compared to manufacturing methods in multilayer cell factories and to a closed system hollow fiber bioreactor, possibly providing an advancement in producing the required numbers of cell作者: guzzle 時(shí)間: 2025-3-24 23:30
Ordinary Psychosis and The Body and the National Institutes of Health. Development of cell therapy follows the same pattern as with small molecules—i.e., discovery, chemistry, manufacturing and controls (CMC), nonclinical pharmacology, pharmacokinetics and toxicology, and, finally, clinical trials with increasing doses, duration,作者: STALE 時(shí)間: 2025-3-25 03:27 作者: Diaphragm 時(shí)間: 2025-3-25 08:06
Organization Design and Engineeringors have all been described. Among the sites where cells have been delivered, the subretinal space is the most commonly described, followed by the vitreous cavity and the suprachoroidal space. Current surgical approaches for accessing these sites include transvitreal and suprachoroidal access. As mo作者: Indolent 時(shí)間: 2025-3-25 13:27
Organization Design and Engineering measures that complement visual function tests to enable multimodal assessment of retinal degenerative diseases. This chapter outlines measures of visual function and retinal structure that are commonly used to diagnose patients with retinal degenerative disease and monitor disease severity during 作者: Frequency 時(shí)間: 2025-3-25 18:10 作者: 潰爛 時(shí)間: 2025-3-25 20:09
Proof of Principle: Preclinical Data on Retinal Cell Transplantation,bits, pigs, and nonhuman primates that model different aspects of the target diseases and therapy delivery. Animal data on retinal cell therapy are reviewed in this chapter. The recent discovery of cell-cell fusion between exogenous and recipient photoreceptor cells—resulting in the transfer of fluo作者: 深淵 時(shí)間: 2025-3-26 01:21 作者: Libido 時(shí)間: 2025-3-26 06:26
Manufacturing of Clinical Grade Cellular Products Under GMP Conditions,been approved as marketed products. Conventional small-scale tissue culture flask based manufacturing methods are compared to manufacturing methods in multilayer cell factories and to a closed system hollow fiber bioreactor, possibly providing an advancement in producing the required numbers of cell作者: 表示問 時(shí)間: 2025-3-26 09:14 作者: Pageant 時(shí)間: 2025-3-26 13:29 作者: 大炮 時(shí)間: 2025-3-26 20:42
Cell Delivery: Surgical Approaches,ors have all been described. Among the sites where cells have been delivered, the subretinal space is the most commonly described, followed by the vitreous cavity and the suprachoroidal space. Current surgical approaches for accessing these sites include transvitreal and suprachoroidal access. As mo作者: fiction 時(shí)間: 2025-3-26 21:09
Diagnosis and Complementary Examinations, measures that complement visual function tests to enable multimodal assessment of retinal degenerative diseases. This chapter outlines measures of visual function and retinal structure that are commonly used to diagnose patients with retinal degenerative disease and monitor disease severity during 作者: assail 時(shí)間: 2025-3-27 04:38 作者: Hyperlipidemia 時(shí)間: 2025-3-27 06:19 作者: MAIZE 時(shí)間: 2025-3-27 12:32
Marco A. Zarbin,Mandeep S. Singh,Ricardo P. CasaroExplores why specific diseases are targeted for cell-based retinal therapy, including evidence that justifies optimism for the approach.Discusses the challenges that must be managed in order to transi作者: Abutment 時(shí)間: 2025-3-27 15:38
Stem Cell Biology and Regenerative Medicinehttp://image.papertrans.cn/c/image/222935.jpg作者: 挑剔為人 時(shí)間: 2025-3-27 19:09 作者: Consequence 時(shí)間: 2025-3-28 01:13
Springer Nature Switzerland AG 2019作者: incubus 時(shí)間: 2025-3-28 02:14 作者: Anthology 時(shí)間: 2025-3-28 09:17
ALIFE?: A Listening Model for Coaching trials of retinal cell therapy that are currently in progress. Approaches of retinal stem cell therapy include “rescue” and “replace” concepts. In the former concept, therapy is directed at retarding the rate of functional decline, whereas in the latter concept, the aim is to restore visual functio作者: Impugn 時(shí)間: 2025-3-28 13:39
Using Somatics to Coach Leadersn with the genetic basis as currently understood. The conditions selected for this chapter have been subdivided into those associated with either a generalized retinal degeneration, such as retinitis pigmentosa, Leber congenital amaurosis, and choroideremia, or those causing degeneration primarily a作者: 欄桿 時(shí)間: 2025-3-28 16:47 作者: ACE-inhibitor 時(shí)間: 2025-3-28 21:21
The Role of Emotions in Coaching. It is anticipated that some of these therapies will be moved into late stage clinical trials, with potential marketing approval in the near future. In order to safely manufacture such products, first for clinical trials, and then later for potential marketing, larger scale Good Manufacturing Pract作者: MEAN 時(shí)間: 2025-3-29 01:51 作者: Mendacious 時(shí)間: 2025-3-29 04:58 作者: Pigeon 時(shí)間: 2025-3-29 09:54 作者: Chronological 時(shí)間: 2025-3-29 14:52
https://doi.org/10.1057/9781137351579 the onset of night blindness, early loss of peripheral vision, and late loss of central vision. Most cases of RP are caused by mutations in rod-specific genes resulting in the demise of rod photoreceptors. However, the subsequent loss of cone photoreceptor function remained a mystery until the rece作者: 懸掛 時(shí)間: 2025-3-29 19:16
Organization Design and Engineeringy limited and can only delay the disease progress. Treatments to restore visual function are limited primarily to retinal prostheses, which require residual inner retinal and optic nerve function and provide vision typically at the ambulatory level or worse. Current research is focusing on the devel作者: 內(nèi)向者 時(shí)間: 2025-3-29 19:46
Organization Design and Engineeringepithelial cells, and choroidal and/or retinal perfusion. The most sensitive measures of disease severity depend on the primary cell damaged in each retinal degeneration. Visual function measures provide information about how the patient experiences the world and therefore provide clinically meaning作者: 廣口瓶 時(shí)間: 2025-3-30 00:29 作者: 多產(chǎn)子 時(shí)間: 2025-3-30 05:16
On Philosophy as a Spiritual Exercisen various retinal degenerative conditions such as age-related macular degeneration (AMD), retinitis pigmentosa, and Stargardt macular dystrophy. The therapeutic cellular substrates include retinal pigment epithelium (RPE) cells derived from embryonic stem cells (ESC) or induced pluripotent stem cell作者: cartilage 時(shí)間: 2025-3-30 11:08
https://doi.org/10.1057/9781137353146ular degeneration, retinitis pigmentosa, and Stargardt disease. Technical improvements are anticipated in areas such as surgical delivery methods, composite cellular patches, and synthetic basement substrates for optimal retinal protection and regeneration. Immunosuppression protocols are being opti作者: Negligible 時(shí)間: 2025-3-30 14:33
Cell-Based Therapy for Degenerative Retinal Disease978-3-030-05222-5Series ISSN 2196-8985 Series E-ISSN 2196-8993
